Sep 14, 2026 07:30AM
Sep 14, 2026 07:30AM
Aug 11, 2026 07:31AM
Aug 11, 2026 07:30AM
Jul 24, 2026 08:00AM
Jul 24, 2026 08:00AM
Jun 23, 2026 05:38AM Organon launches two denosumab biosimilars in Canada
Jun 23, 2026 05:30AM
Jun 22, 2026 07:30AM
Jun 22, 2026 07:30AM
Jun 10, 2026 07:30AM
Jun 10, 2026 07:30AM
Apr 30, 2026 07:30AM
Apr 29, 2026 10:00AM European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
Apr 29, 2026 05:52AM
Apr 29, 2026 05:30AM
Apr 15, 2026 07:30AM
Apr 15, 2026 07:30AM
Mar 27, 2026 08:01AM
Mar 27, 2026 08:00AM
Feb 27, 2026 08:00AM Organon's VTAMA cream shows sleep improvements in pediatric atopic dermatitis study
Feb 27, 2026 08:00AM
Feb 23, 2026 07:30AM
Feb 23, 2026 07:30AM
Feb 16, 2026 05:31PM
Feb 12, 2026 07:30AM
Jan 16, 2026 09:12PM
Nov 17, 2025 04:04PM Form 4 Organon & Co. For: Nov 13 Filed by: Morrissey Joseph T. Jr.
Nov 17, 2025 05:30AM
Nov 17, 2025 05:30AM
Nov 10, 2025 07:30AM
Nov 8, 2025 08:00AM
Sep 19, 2025 06:00AM
Sep 19, 2025 06:00AM
Sep 2, 2025 05:31AM FDA approves Henlius and Organon's denosumab biosimilars BILDYOS and BILPREVDA
Sep 2, 2025 05:30AM
Aug 5, 2025 07:30AM
Jul 7, 2025 07:31AM
Jul 7, 2025 07:30AM
May 27, 2025 07:34AM
May 27, 2025 07:30AM
May 1, 2025 07:00AM Organon Reports Results for the First Quarter Ended March 31, 2025
Apr 1, 2025 07:31AM
Apr 1, 2025 07:30AM
Mar 28, 2025 06:00AM
Mar 10, 2025 12:01AM
Mar 8, 2025 09:00AM
Feb 13, 2025 07:30AM
Dec 16, 2024 07:30AM Organon (OGN) Announces FDA Approval of VTAMA cream
Dec 16, 2024 07:30AM

332,796 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All